| UHC Medicare Advantage | Spine Procedures - Medicare Advantage Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Abnormal Uterine Bleeding and Uterine Fibroids - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Ambulance Services - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Apheresis - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Autologous Cellular Therapy - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Beds and Mattresses - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Botulinum Toxins A and B - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Breast Reconstruction - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Breast Reduction Surgery - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Briumvi® (Ublituximab-Xiiy) - Commercial Medical Benefit Drug Policy | 2026-01-01 |